194 related articles for article (PubMed ID: 15307601)
1. [The central action of botulinum toxin type A assessed by brain auditory and somatosensory evoked potentials].
Sławek J; Recławowicz D
Neurol Neurochir Pol; 2004; 38(2):93-9. PubMed ID: 15307601
[TBL] [Abstract][Full Text] [Related]
2. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
3. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
4. Somatosensory evoked potentials of hand muscles in stroke and their modification by botulinum toxin: a preliminary study.
Basaran A; Emre U; Karadavut KI; Bulmus N
J Rehabil Med; 2012 Jun; 44(7):541-6. PubMed ID: 22674234
[TBL] [Abstract][Full Text] [Related]
5. Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.
Urban PP; Rolke R
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1541-6. PubMed ID: 15489383
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
7. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
Domzał TM
Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
[TBL] [Abstract][Full Text] [Related]
8. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
Park ES; Park CI; Kim DY; Kim YR
Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
[TBL] [Abstract][Full Text] [Related]
9. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
10. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
12. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy.
Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V
Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744
[TBL] [Abstract][Full Text] [Related]
13. Interside Latency Differences in Brainstem Auditory and Somatosensory Evoked Potentials. Defining Upper Limits to Determine Asymmetry.
Moncho D; Poca MA; Minoves T; Ferré A; Sahuquillo J
J Clin Neurophysiol; 2015 Oct; 32(5):424-7. PubMed ID: 26061480
[TBL] [Abstract][Full Text] [Related]
14. [Aspects of the complexity of cervical dystonia].
Hefter H
Nervenarzt; 2008 Jun; 79 Suppl 1():15-8. PubMed ID: 18927959
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
Naumann M; Yakovleff A; Durif F;
J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
[TBL] [Abstract][Full Text] [Related]
17. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study.
Werdelin L; Dalager T; Fuglsang-Frederiksen A; Regeur L; Karlsborg M; Korbo L; Munck O; Winge K
Clin Neurophysiol; 2011 Nov; 122(11):2305-9. PubMed ID: 21636319
[TBL] [Abstract][Full Text] [Related]
18. Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study.
Opavský R; Hluštík P; Otruba P; Kaňovský P
Int J Neurosci; 2012 Jan; 122(1):45-52. PubMed ID: 21919815
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]